CARAMORI, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 23.135
AS - Asia 12.370
EU - Europa 7.356
SA - Sud America 2.180
Continente sconosciuto - Info sul continente non disponibili 319
AF - Africa 258
OC - Oceania 47
Totale 45.665
Nazione #
US - Stati Uniti d'America 22.603
SG - Singapore 4.437
CN - Cina 3.151
IT - Italia 1.884
BR - Brasile 1.673
UA - Ucraina 1.517
VN - Vietnam 1.394
DE - Germania 1.133
HK - Hong Kong 1.118
TR - Turchia 849
GB - Regno Unito 659
FI - Finlandia 581
FR - Francia 438
RU - Federazione Russa 325
JP - Giappone 305
BD - Bangladesh 269
SE - Svezia 266
MX - Messico 209
IN - India 208
CA - Canada 207
PL - Polonia 196
AR - Argentina 181
ID - Indonesia 131
IQ - Iraq 95
ZA - Sudafrica 90
NL - Olanda 78
CO - Colombia 74
EC - Ecuador 74
PK - Pakistan 59
PY - Paraguay 44
MY - Malesia 43
PH - Filippine 42
AU - Australia 41
VE - Venezuela 41
ES - Italia 40
CL - Cile 37
MA - Marocco 37
SA - Arabia Saudita 33
UZ - Uzbekistan 33
AE - Emirati Arabi Uniti 32
BE - Belgio 31
LT - Lituania 31
EG - Egitto 26
KE - Kenya 26
TN - Tunisia 26
CR - Costa Rica 25
JM - Giamaica 24
PE - Perù 23
UY - Uruguay 21
AT - Austria 19
KZ - Kazakistan 19
NP - Nepal 19
CH - Svizzera 18
CZ - Repubblica Ceca 18
IE - Irlanda 18
KR - Corea 17
RO - Romania 16
BG - Bulgaria 15
AL - Albania 14
TW - Taiwan 13
IL - Israele 11
DZ - Algeria 10
JO - Giordania 10
LB - Libano 10
SV - El Salvador 10
BO - Bolivia 9
ET - Etiopia 9
HN - Honduras 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
HU - Ungheria 8
IR - Iran 8
OM - Oman 8
BB - Barbados 7
BY - Bielorussia 7
EU - Europa 7
GT - Guatemala 7
PT - Portogallo 7
BH - Bahrain 6
HR - Croazia 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
DO - Repubblica Dominicana 5
GR - Grecia 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
CG - Congo 4
CI - Costa d'Avorio 4
MN - Mongolia 4
PS - Palestinian Territory 4
RS - Serbia 4
TH - Thailandia 4
AO - Angola 3
KG - Kirghizistan 3
KH - Cambogia 3
MM - Myanmar 3
MU - Mauritius 3
NO - Norvegia 3
PA - Panama 3
Totale 45.294
Città #
Singapore 2.753
Fairfield 2.049
Ashburn 1.998
Woodbridge 1.897
Jacksonville 1.600
San Jose 1.491
Houston 1.234
Chandler 1.143
Hong Kong 1.109
Santa Clara 974
Ann Arbor 861
Wilmington 765
Beijing 758
Seattle 737
Council Bluffs 686
Cambridge 591
Izmir 534
Nanjing 527
Ho Chi Minh City 463
Princeton 331
Munich 318
Hanoi 312
New York 312
Tokyo 290
Los Angeles 283
Milan 265
Lauterbourg 257
Helsinki 235
Washington 222
Dallas 220
Warsaw 187
San Diego 180
Ferrara 153
Mexico City 146
Boardman 145
Shenyang 144
São Paulo 134
Nanchang 132
Rome 109
Hebei 101
Chicago 96
Changsha 93
Tianjin 90
Jiaxing 87
Addison 86
Hefei 84
Shanghai 84
Toronto 79
Dearborn 70
Orem 64
London 63
Da Nang 60
Buffalo 59
Haiphong 59
Jinan 59
Moscow 58
Brooklyn 57
Naples 56
Rio de Janeiro 54
Chennai 50
Verona 50
Jakarta 49
Norwalk 47
Kunming 45
Frankfurt am Main 43
Phoenix 43
Atlanta 40
Guangzhou 40
Zhengzhou 40
Redwood City 38
Boston 37
Ningbo 37
Turku 37
Baghdad 36
Falls Church 36
Mountain View 36
The Dalles 36
Johannesburg 35
Belo Horizonte 34
Hải Dương 34
Montreal 34
San Francisco 33
Bologna 32
Curitiba 31
Denver 30
Florence 30
Campinas 29
Taizhou 29
Kuala Lumpur 27
Quito 27
Brussels 26
Mumbai 26
Brasília 25
Bremen 25
Amsterdam 24
Bogotá 24
Orange 24
Poplar 24
Tashkent 24
Turin 24
Totale 29.395
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 547
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 513
Expiratory flow limitation as a risk factor for pulmonary complications after major abdominal surgery 388
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 353
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 353
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 334
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 324
Targeting Th2 cells in asthmatic airways 309
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 293
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 289
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 273
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 253
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 242
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 242
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 240
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 229
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 228
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 226
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 224
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 224
Activation of NF-kappaB transcription factor in asthma death 219
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 219
Malattie polmonari primitive da cause dismetaboliche. 218
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 217
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 217
Cellule staminali e patologia polmonare dell’adulto 216
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 214
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 214
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 213
Sindrome epatopolmonare. 212
COPD exacerbations: definitions and classifications 209
A link between lung injury and inflammatory myopathies: making the diagnosis 209
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 209
Airway obstruction in chronic obstructive pulmonary disease. 209
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes 206
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 205
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 203
Definizione e classificazione delle broncopneumopatie croniche ostruttive. 200
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 200
Models of infection and exacerbations in COPD. 198
Birbeck granules: contribution to the comprehnsion of intracytoplasmic evolution 197
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare. 196
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 196
Ectopic thymoma simulating a pericardial cyst: case report 196
Definition, clinical features, investigations and differential diagnosis in asthma. 189
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 188
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 188
Corticosteroidi, disodiocromoglicato e nedocromile nella terapia dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 187
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 186
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 185
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 185
Extrapulmonary tuberculosis 185
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 184
Asthma: A Chronic Infectious Disease? 183
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus 182
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 181
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression 180
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 180
Convergent sets of data from In Vivo and In Vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis 179
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study 179
Anti-inflammatory treatments for asthma: Past, present, future 178
STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects 178
Allergen responses modified by a GATA3 DNAzyme 178
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 178
Mechanisms involved in lung cancer development in COPD 177
Near-fatal asthma phenotype in the ENFUMOSA cohort 176
Malattie della pleura 176
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 176
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 175
Clinical definition of COPD exacerbations and classification of their severity 174
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 174
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: An overview 173
Molecular mechanisms of respiratory virus-induced inflammation. 172
Steroid-sparing Strategies: Other Combinations 171
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 171
Transcription Factors: Overview 171
Chronic obstructive pulmonary disease international guidelines 171
Interactions of airway pathogens and inflammatory processes 171
Pathophysiology of viral-induced exacerbations of COPD 168
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 168
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease 166
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 166
Respiratory mechanics at different PEEP level during Anaesthesia in elderly: a pilot study. 166
The level of control of mild asthma in general practice: An observational community-based study 166
Anatomia e fisiologia clinica della pleura. 165
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation 164
Interactions of airway pathogens and inflammatory processes 164
Therapies acting on transcription: overview. 164
STAT2 activation in smokers and patients with chronic obstructive pulmonary disease 163
Asma e leucotrieni 163
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 162
New insights into the molecular mechanisms of corticosteroids actions 161
Chronic Obstructive pulmonary disease and lung cancer: New molecular insights 160
Gender and respiratory infections. 159
COPD pathology in the small airways 158
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 157
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 156
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 156
COPD immunopathology 156
New drugs targeting Th2 lymphocytes in asthma 153
Totale 20.718
Categoria #
all - tutte 207.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 33.016
Totale 240.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.220 0 0 199 218 74 94 99 163 93 235 265 780
2022/20232.619 350 61 78 324 375 457 69 244 360 25 183 93
2023/20241.103 148 171 53 30 86 139 27 47 23 37 42 300
2024/20255.145 186 114 429 135 636 401 192 414 848 734 587 469
2025/202615.599 1.218 906 1.451 2.132 2.080 962 1.552 1.108 1.478 1.781 579 352
2026/20272.294 508 917 869 0 0 0 0 0 0 0 0 0
Totale 45.665